Cargando…
Schlafen 11 expression in human acute leukemia cells with gain-of-function mutations in the interferon-JAK signaling pathway
Schlafen11 (SLFN11) is referred to as interferon (IFN)-inducible. Based on cancer genomic databases, we identified human acute myeloid and lymphoblastic leukemia cells with gain-of-function mutations in the Janus kinase (JAK) family as exhibiting high SLFN11 expression. In these cells, the clinical...
Autores principales: | Murai, Yasuhisa, Jo, Ukhyun, Murai, Junko, Fukuda, Shinsaku, Takebe, Naoko, Pommier, Yves |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517841/ https://www.ncbi.nlm.nih.gov/pubmed/34693224 http://dx.doi.org/10.1016/j.isci.2021.103173 |
Ejemplares similares
-
Precision Oncology with Drugs Targeting the Replication Stress, ATR, and Schlafen 11
por: Jo, Ukhyun, et al.
Publicado: (2021) -
SLFN11’s surveillance role in protein homeostasis
por: Murai, Yasuhisa, et al.
Publicado: (2022) -
Structural, molecular, and functional insights into Schlafen proteins
por: Jo, Ukhyun, et al.
Publicado: (2022) -
SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors
por: Jo, Ukhyun, et al.
Publicado: (2021) -
Prognostic impact of Schlafen 11 in bladder cancer patients treated with platinum‐based chemotherapy
por: Taniyama, Daiki, et al.
Publicado: (2021)